Succinate Dehydrogenase is the Regulator of Respiration in Mycobacterium tuberculosis

PLoS Pathogens

Volumn 10, Issue 11, 2014, Pages

  Hartman, Travis ^a   Weinrick, Brian ^a   Vilchèze, Catherine ^a   Berney, Michael ^a   Tufariello, Joanne ^a   Cook, Gregory M ^b   Jacobs, William R ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CYTOCHROME C OXIDASE; DISSOLVED OXYGEN; DITHIOTHREITOL; GLUCOSE; GLYCEROL; MENAQUINONE; NITRIC OXIDE REDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REGULATOR PROTEIN; SUCCINATE DEHYDROGENASE; SUCCINIC ACID; TETRAPHENYLPHOSPHONIUM; BACTERIAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BATCH CELL CULTURE; CELL HYPOXIA; CELL MEMBRANE POTENTIAL; CITRIC ACID CYCLE; COLONY FORMING UNIT; CONTINUOUS CULTURE; CONTROLLED STUDY; ENZYME INHIBITION; EVOLUTIONARY ADAPTATION; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; HIGH THROUGHPUT SCREENING; ISOTOPE LABELING; MASS SPECTROMETRY; METABOLIC REGULATION; METABOLOMICS; MICROBIAL RESPIRATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; OPERON; OVERLAPPING GENE; OXIDATION REDUCTION POTENTIAL; OXYGEN CONSUMPTION; PROTON MOTIVE FORCE; RESPIRATORY CHAIN; SEQUENCE ALIGNMENT; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL; BIOLOGICAL MODEL; ENZYMOLOGY; GENETICS; KNOCKOUT MOUSE; METABOLISM; MICROBIAL VIABILITY; PHYSIOLOGY;

MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; BACTERIAL PROTEINS; MICE; MICE, KNOCKOUT; MICROBIAL VIABILITY; MODELS, BIOLOGICAL; MYCOBACTERIUM TUBERCULOSIS; OXYGEN CONSUMPTION; SUCCINATE DEHYDROGENASE;

EID: 84912100029     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004510     Document Type: Article

References (63)

1. World Health Organization (2013) Global Tuberculosis Report 2013. 2013th ed. Geneva, Switzerland: WHO Press. Available: http://apps.who.int/iris/handle/10665/91355.
2. Tufariello JM, Chan J, Flynn JL, (2003) Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis 3: 578–590 Available: http://www.ncbi.nlm.nih.gov/pubmed/12954564
3. Gengenbacher M, Kaufmann SHE, (2012) Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol Rev 36: 514–532 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3319523&tool=pmcentrez&rendertype=abstract
4. CORPER HJ, COHN ML, (1951) The viability and virulence of old cultures of tubercle bacilli; studies on 30-year-old broth cultures maintained at 37 degrees C. Tubercle 32: 232–237 Available: http://www.ncbi.nlm.nih.gov/pubmed/14893467
5. Wayne LG, Hayes LG, (1996) An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 64: 2062–2069 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=174037&tool=pmcentrez&rendertype=abstract
6. Gengenbacher M, Rao SPS, Pethe K, Dick T, (2010) Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability. Microbiology 156: 81–87 Available: http://mic.sgmjournals.org/cgi/content/abstract/156/1/81
7. Watanabe S, Zimmermann M, Goodwin MB, Sauer U, Barry CE, et al. (2011) Fumarate reductase activity maintains an energized membrane in anaerobic Mycobacterium tuberculosis. PLoS Pathog 7: e1002287 Available: http://dx.plos.org/10.1371/journal.ppat.1002287
8. Koul A, Vranckx L, Dendouga N, Balemans W, Van den Wyngaert I, et al. (2008) Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis. J Biol Chem 283: 25273–25280 Available: http://www.ncbi.nlm.nih.gov/pubmed/18625705
9. Beste DJ V, Espasa M, Bonde B, Kierzek AM, Stewart GR, et al. (2009) The genetic requirements for fast and slow growth in mycobacteria. PLoS One 4: e5349 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2685279&tool=pmcentrez&rendertype=abstract
10. Sassetti CM, Rubin EJ, (2003) Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci U S A 100: 12989–12994 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=240732&tool=pmcentrez&rendertype=abstract
11. Kaushal D, Schroeder BG, Tyagi S, Yoshimatsu T, Scott C, et al. (2002) Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH. Proc Natl Acad Sci U S A 99: 8330–8335 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=123067&tool=pmcentrez&rendertype=abstract
12. Zhang YJ, Reddy MC, Ioerger TR, Rothchild AC, Dartois V, et al. (2013) Tryptophan biosynthesis protects mycobacteria from CD4 T-cell-mediated killing. Cell 155: 1296–1308 Available: http://www.sciencedirect.com/science/article/pii/S0092867413013639
13. Zhang Y, Yew WW, Barer MR, (2012) Targeting persisters for tuberculosis control. Antimicrob Agents Chemother 56: 2223–2230 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3346619&tool=pmcentrez&rendertype=abstract
14. Berney M, Cook GM, (2010) Unique flexibility in energy metabolism allows mycobacteria to combat starvation and hypoxia. PLoS One 5: e8614 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2799521&tool=pmcentrez&rendertype=abstract
15. Bardarov S, Bardarov S, JrPavelka MS, JrSambandamurthy V, Larsen M, et al. (2002) Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 148: 3007–3017 Available: http://www.ncbi.nlm.nih.gov/pubmed/12368434
16. Jain P, Hsu T, Arai M, Biermann K, Thaler DS, et al. (2014) Specialized transduction designed for precise high-throughput unmarked deletions in Mycobacterium tuberculosis. MBio 5: e01245–14 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4049104&tool=pmcentrez&rendertype=abstract
17. Cecchini G, Schröder I, Gunsalus RP, Maklashina E, (2002) Succinate dehydrogenase and fumarate reductase from Escherichia coli. Biochim Biophys Acta 1553: 140–157 Available: http://www.ncbi.nlm.nih.gov/pubmed/11803023
18. Lemos RS, Fernandes AS, Pereira MM, Gomes CM, Teixeira M, (2002) Quinol:fumarate oxidoreductases and succinate:quinone oxidoreductases: phylogenetic relationships, metal centres and membrane attachment. Biochim Biophys Acta 1553: 158–170 Available: http://www.ncbi.nlm.nih.gov/pubmed/11803024
19. Drancourt M, Bavesh D.Kana, Machowski EE, Schechter N, Teh J-S, et al. (2009) Mycobacterium: Genomics and Molecular Biology. Caister Academic Press. Available: http://books.google.com/books?hl=en&lr=&id=2UFkCKT6K8sC&pgis=1.
20. Baughn AD, Garforth SJ, Vilchèze C, Jacobs WR, (2009) An anaerobic-type alpha-ketoglutarate ferredoxin oxidoreductase completes the oxidative tricarboxylic acid cycle of Mycobacterium tuberculosis. PLoS Pathog 5: e1000662 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2773412&tool=pmcentrez&rendertype=abstract
21. Eoh H, Rhee KY, (2013) Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 110: 6554–6559 Available: http://www.pnas.org/content/110/16/6554.short
22. Pecsi I, Hards K, Ekanayaka N, Berney M, Hartman T, et al. (2014) Essentiality of Succinate Dehydrogenase in Mycobacterium smegmatis and Its Role in the Generation of the Membrane Potential Under Hypoxia. MBio 5: e01093–14 Available: http://www.ncbi.nlm.nih.gov/pubmed/25118234
23. Felle H, Porter JS, Slayman CL, Kaback HR, (1980) Quantitative measurements of membrane potential in Escherichia coli. Biochemistry 19: 3585–3590 Available: http://pubs.acs.org/doi/abs/10.1021/bi00556a026
24. Madej MG, Nasiri HR, Hilgendorff NS, Schwalbe H, Unden G, et al. (2006) Experimental evidence for proton motive force-dependent catalysis by the diheme-containing succinate:menaquinone oxidoreductase from the Gram-positive bacterium Bacillus licheniformis. Biochemistry 45: 15049–15055 Available: http://dx.doi.org/10.1021/bi0618161
25. Schirawski J, Unden G, (1998) Menaquinone-dependent succinate dehydrogenase of bacteria catalyzes reversed electron transport driven by the proton potential. Eur J Biochem 257: 210–215 Available: http://www.ncbi.nlm.nih.gov/pubmed/9799121
26. Cox RA, Cook GM (2007) Growth regulation in the mycobacterial cell. Curr Mol Med: 231–245. Available: http://www.ingentaconnect.com/content/ben/cmm/2007/00000007/00000003/art00002.
27. Kröger A, Klingenberg M, (1973) The kinetics of the redox reactions of ubiquinone related to the electron-transport activity in the respiratory chain. Eur J Biochem 34: 358–368 Available: http://www.ncbi.nlm.nih.gov/pubmed/4351161
28. Dry IB, Moore AL, Day DA, Wiskich JT, (1989) Regulation of alternative pathway activity in plant mitochondria: nonlinear relationship between electron flux and the redox poise of the quinone pool. Arch Biochem Biophys 273: 148–157 Available: http://www.sciencedirect.com/science/article/pii/0003986189901732
29. Lemma E, Unden G, Kröger A, (1990) Menaquinone is an obligatory component of the chain catalyzing succinate respiration in Bacillus subtilis. Arch Microbiol 155: 62–67 Available: http://link.springer.com/article/10.1007/BF00291276
30. Zhang YJ, Ioerger TR, Huttenhower C, Long JE, Sassetti CM, et al. (2012) Global Assessment of Genomic Regions Required for Growth in Mycobacterium tuberculosis. PLoS Pathog 8: e1002946 Available: http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1002946#
31. Kaufmann SH, Ladel CH, (1994) Role of T cell subsets in immunity against intracellular bacteria: experimental infections of knock-out mice with Listeria monocytogenes and Mycobacterium bovis BCG. Immunobiology 191: 509–519 Available: http://www.ncbi.nlm.nih.gov/pubmed/7713565
32. Tsai MC, Chakravarty S, Zhu G, Xu J, Tanaka K, et al. (2006) Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbiol 8: 218–232 Available: http://www.ncbi.nlm.nih.gov/pubmed/16441433
33. Driver ER, Ryan GJ, Hoff DR, Irwin SM, Basaraba RJ, et al. (2012) Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis. Antimicrob Agents Chemother 56: 3181–3195 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3370740&tool=pmcentrez&rendertype=abstract
34. Wayne LG, Sohaskey CD, (2001) Nonreplicating persistence of mycobacterium tuberculosis. Annu Rev Microbiol 55: 139–163 Available: http://www.annualreviews.org/doi/pdf/10.1146/annurev.micro.55.1.139
35. Loebel RO, Shorr E, Richardson HB, (1933) The Influence of Adverse Conditions upon the Respiratory Metabolism and Growth of Human Tubercle Bacilli. J Bacteriol 26: 167–200 Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC533551/
36. Wayne LG, Hayes LG, (1996) An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 64: 2062–2069 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=174037&tool=pmcentrez&rendertype=abstract
37. Elliott SJ, Léger C, Pershad HR, Hirst J, Heffron K, et al. (2002) Detection and interpretation of redox potential optima in the catalytic activity of enzymes. Biochim Biophys Acta 1555: 54–59 Available: http://www.ncbi.nlm.nih.gov/pubmed/12206891
38. Wang Q, Zhang Y, Yang C, Xiong H, (2010) Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science 327: 1004–1007 Available: http://stke.sciencemag.org/cgi/content/abstract/sci;327/5968/1004
39. Nam T-W, Park Y-H, Jeong H-J, Ryu S, Seok Y-J, (2005) Glucose repression of the Escherichia coli sdhCDAB operon, revisited: regulation by the CRP*cAMP complex. Nucleic Acids Res 33: 6712–6722 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1297706&tool=pmcentrez&rendertype=abstract
40. Zhang Z, Huang L, Shulmeister VM, Chi YI, Kim KK, et al. (1998) Electron transfer by domain movement in cytochrome bc1. Nature 392: 677–684 Available: http://www.ncbi.nlm.nih.gov/pubmed/9565029
41. Hunte C, Palsdottir H, Trumpower BL, (2003) Protonmotive pathways and mechanisms in the cytochrome bc1 complex. FEBS Lett 545: 39–46 Available: http://linkinghub.elsevier.com/retrieve/pii/S0014579303003910
42. Mitchell P, (1975) Protonmotive redox mechanism of the cytochrome b-c1 complex in the respiratory chain: protonmotive ubiquinone cycle. FEBS Lett 56: 1–6 Available: http://linkinghub.elsevier.com/retrieve/pii/S0014579303003910
43. Bekker M, Kramer G, Hartog AF, Wagner MJ, de Koster CG, et al. (2007) Changes in the redox state and composition of the quinone pool of Escherichia coli during aerobic batch-culture growth. Microbiology 153: 1974–1980 Available: http://mic.sgmjournals.org/content/153/6/1974.full
44. Voskuil MI, (2004) Mycobacterium tuberculosis gene expression during environmental conditions associated with latency. Tuberculosis (Edinb) 84: 138–143 Available: http://www.ncbi.nlm.nih.gov/pubmed/15207483
45. Shi L, Sohaskey CD, Kana BD, Dawes S, North RJ, et al. (2005) Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration. Proc Natl Acad Sci U S A 102: 15629–15634 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1255738&tool=pmcentrez&rendertype=abstract
46. De Souza N, (2007) Too much of a good thing. Nat Methods 4: 386–386 Available: http://www.nature.com/nature/journal/vaop/ncurrent/full/472159a.html
47. Andreu J, Cáceres J, Pallisa E, Martinez-Rodriguez M, (2004) Radiological manifestations of pulmonary tuberculosis. Eur J Radiol 51: 139–149 Available: http://www.ncbi.nlm.nih.gov/pubmed/15246519
48. Mitchison DA, Chang KC, (2009) Experimental models of tuberculosis: can we trust the mouse? Am J Respir Crit Care Med 180: 201–202 Available: http://www.ncbi.nlm.nih.gov/pubmed/19633155
49. Young D, (2009) Animal models of tuberculosis. Eur J Immunol 39: 2011–2014 Available: http://www.ncbi.nlm.nih.gov/pubmed/19672894
50. Barry CE, Boshoff HI, Dartois V, Dick T, Ehrt S, et al. (2009) The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 7: 845–855 Available: http://www.ncbi.nlm.nih.gov/pubmed/19855401
51. Gomez JE, McKinney JD, (2004) M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis 84: 29–44 Available: http://linkinghub.elsevier.com/retrieve/pii/S1472979203000866
52. Neyrolles O, Hernández-Pando R, Pietri-Rouxel F, Fornès P, Tailleux L, et al. (2006) Is adipose tissue a place for Mycobacterium tuberculosis persistence? PLoS One 1: e43 Available: http://dx.plos.org/10.1371/journal.pone.0000043
53. Das B, Kashino SS, Pulu I, Kalita D, Swami V, et al. (2013) CD271+ Bone Marrow Mesenchymal Stem Cells May Provide a Niche for Dormant Mycobacterium tuberculosis. Sci Transl Med 5: 170ra13 Available: http://www.ncbi.nlm.nih.gov/pubmed/23363977
54. Filippini P, Iona E, Piccaro G, Peyron P, Neyrolles O, et al. (2010) Activity of drug combinations against dormant Mycobacterium tuberculosis. Antimicrob Agents Chemother 54: 2712–2715 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2876400&tool=pmcentrez&rendertype=abstract
55. De Carvalho LPS, Fischer SM, Marrero J, Nathan C, Ehrt S, et al. (2010) Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates. Chem Biol 17: 1122–1131 Available: http://www.ncbi.nlm.nih.gov/pubmed/21035735
56. Borisov VB, Murali R, Verkhovskaya ML, Bloch D a, Han H, et al. (2011) Aerobic respiratory chain of Escherichia coli is not allowed to work in fully uncoupled mode. Proc Natl Acad Sci U S A 108: 17320–17324 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3198357&tool=pmcentrez&rendertype=abstract
57. Baek S-H, Li AH, Sassetti CM, (2011) Metabolic regulation of mycobacterial growth and antibiotic sensitivity. PLoS Biol 9: e1001065 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3101192&tool=pmcentrez&rendertype=abstract
58. Andries K, Verhasselt P, Guillemont J, Göhlmann HWH, Neefs J-M, et al. (2005) A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307: 223–227 Available: http://www.ncbi.nlm.nih.gov/pubmed/15591164
59. Diacon AH, Pym A, (2009) The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med 360: 2397–2405 Available: http://www.nejm.org/doi/full/10.1056/nejmoa0808427
60. Diacon AH, Dawson R, von Groote-Bidlingmaier F, Symons G, Venter A, et al. (2012) 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial. Lancet 380: 986–993 Available: http://www.ncbi.nlm.nih.gov/pubmed/22828481
61. Sambandamurthy VK, Wang X, Chen B, Russell RG, Derrick S, et al. (2002) A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Nat Med 8: 1171–1174 Available: http://www.ncbi.nlm.nih.gov/pubmed/12219086
62. Notredame C, Higgins DG, Heringa J, (2000) T-Coffee: A novel method for fast and accurate multiple sequence alignment. J Mol Biol 302: 205–217 Available: http://www.ncbi.nlm.nih.gov/pubmed/10964570
63. Paglia G, Hrafnsdóttir S, Magnúsdóttir M, Fleming RMT, Thorlacius S, et al. (2012) Monitoring metabolites consumption and secretion in cultured cells using ultra-performance liquid chromatography quadrupole-time of flight mass spectrometry (UPLC-Q-ToF-MS). Anal Bioanal Chem 402: 1183–1198 Available: http://www.ncbi.nlm.nih.gov/pubmed/22159369